Implantable cardiac patches and injectable hydrogels are among the most promising
therapies for cardiac tissue regeneration following myocardial infarction. Incorporating …

For many patients with terminal/advanced cardiac failure, heart transplantation is the most
effective, durable treatment option, and offers the best prospects for a high quality of life. The …

Background A shortage of donation after brain death (DBD) donors for heart transplantation
(HT) persists. Recent improvements in organ procurement from donation after circulatory …

Approximately 65 million adults globally have heart failure, and the prevalence is expected
to increase substantially with ageing populations. Despite advances in pharmacological and …

There are only 2 treatments for the thousands of patients who progress to the most
advanced form of heart failure despite the application of guideline-based medical therapy …

Cardiovascular diseases are one of the leading causes of death globally. Among various
cardiovascular diseases, myocardial infarction is an important one. Compared with …

Ischemic heart disease and myocardial infarction remain leading causes of mortality
worldwide. Existing myocardial infarction treatments are incapable of fully repairing and …

Ischemic cardiomyopathy (ICM) affect millions of patients globally. Decellularized
extracellular matrix materials (dECM) have components, microstructure and mechanical …

Donation after circulatory death (DCD) represents a promising opportunity to overcome the
relative shortage of donors for heart transplantation. However, the necessary period of warm …

Purpose We sought to develop and validate machine learning (ML) models to increase the
predictive accuracy of mortality after heart transplantation (HT). Methods and results We …